New liver dialysis machine could save lives in severe liver failure
NCT ID NCT07347275
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called DIALIVE 2.0, which acts like a dialysis machine for the liver, in people with severe acute-on-chronic liver failure (ACLF). The goal is to see if adding up to 7 daily treatments to standard care helps more patients recover from liver failure and survive without needing a liver transplant. The trial will include 72 adults aged 18-70 with advanced ACLF across UK hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••